Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRSP
CRSP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRSP News
CRISPR Therapeutics Faces Commercialization Challenges
2d ago
Fool
CRISPR Therapeutics Faces Market Challenges Amid Progress
2d ago
NASDAQ.COM
Biotech Sector Thrives with Strong Growth Potential
2d ago
Fool
Investment Opportunities in Biotech Stocks
2d ago
NASDAQ.COM
Investment Portfolio Strategy Analysis
2d ago
Fool
Investment Strategy Analysis for Blue Chip Stocks
2d ago
NASDAQ.COM
CRISPR Therapeutics Faces Stagnant Stock Despite Promising Pipeline
Jun 08 2026
Fool
CRISPR Therapeutics Shows Promising Future Potential
Jun 03 2026
Fool
CRISPR's Casgevy Establishes Leadership in Gene-Editing Therapies
Jun 03 2026
NASDAQ.COM
Eli Lilly's Gene Editing Drug Shows Significant Progress
Jun 03 2026
Fool
Eli Lilly Reports Positive Results for Gene Editing Candidate
Jun 03 2026
NASDAQ.COM
FDA Issues Draft Guidance to Accelerate Gene Therapy Development
Jun 02 2026
seekingalpha
CRISPR Therapeutics' CTX611: A Potential Game Changer in Anticoagulants
Jun 01 2026
Fool
Investment Choices in Gene Editing Sector
May 31 2026
NASDAQ.COM
Investment Choices in Gene Editing Technology
May 31 2026
Fool
Investment Choices in Gene Editing Technology
May 31 2026
Yahoo Finance
Show More News
